Association between Three Therapeutic Strategies and Clinical Outcomes of 2009 FIGO Stage IB2/IIA2 Cervical Cancer

Table 5

Frequency of acute and late toxicities.

Toxicity	PST (n = 104) n (%)		NAC + RS (n = 53) n (%)		CCRT (n = 49) n (%)
	G1-2	G3-4	G1-2	G3-4	G1-2	G3-4	—
Leukopenia	30 (28.8)	11 (10.6)	17 (32.1)	12 (22.6)	22 (44.9)	17 (34.7)	0.248
Neutropenia	21 (20.2)	10 (9.6)	12 (22.6)	11 (20.8)	24 (49.0)	12 (24.5)	0.435
Thrombocytopenia	6 (5.8)	3 (2.9)	3 (5.7)	1 (1.9)	17 (34.7)	1 (2.0)	0.116
Anemia	9 (8.7)	4 (3.8)	7 (13.2)	11 (20.8)	10 (20.4)	6 (12.2)	0.190
Hepatotoxicity	5 (4.8)	0	4 (7.5)	0	5 (10.2)	0	0.931
Thrombosis	0	1 (1.0)	0	0	0	0	0.777
Lower extremity lymphedema	0	4 (3.8)	0	5 (9.4)	0	0
Bowel obstruction	0	3 (2.9)	0	1 (1.9)	0	0
Radiation-induced rectitis	0	0	0	0	0	4 (8.2)
Radiation induced cystitis	0	0	0	0	0	0
Femoral head necrosis	0	0	0	0	0	1 (2.0)